Jeffrey Vacirca, MD | Authors

The 340b Drug Discount Program: Oncology's Optical Illusion

November 15, 2013

The historical rationale for the 340b program is a good one: indigent patients do need reliable access to prescription drugs, and entities meeting this need should be supported. However, the evolution of the 340b program has strayed widely from its original intent.